Nephros Stock Forecast for 2023 - 2025 - 2030

Updated on 04/27/2024

Stock Rating
-12
Price Target
$4.75
Consensus
Outperform
Upside
116.89%
Analysts
0
Stock Rating
-12
Upside
116.89%
Analysts
0
Price Target
$4.75

Nephros Stock Forecast and Price Target

The average target price for Nephros's stock set by renowned analysts in recent months is $4.75, representing a potential upside of approximately 116.89% from its last closing price if met by 2025. This estimation is based on a high estimate of $5.00 and a low estimate of $4.50. If you're interested in investing in this company, why not also look at its competitors to see how they are doing?

$4.75

116.89% Upside

Buy
Buy

Nephros Fair Value Forecast for 2023 - 2025 - 2030

Nephros's Price has grown In the last four years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $2.36 – an increase of 100.00%. For the next seven years, experts predict that Nephros's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$2.36
2025 Fair Value Forecast
$2.62
2026 Fair Value Forecast
$2.91
2027 Fair Value Forecast
$3.24
2028 Fair Value Forecast
$3.60
2029 Fair Value Forecast
$4.00
2030 Fair Value Forecast
$4.45

Nephros Revenue Forecast for 2023 - 2025 - 2030

Nephros's Revenue has grown In the last two years, rising from $8.56M to $9.98M – a growth of 16.59%. In the next year, analysts believe that Revenue will reach $17.05M – an increase of 70.84%. For the next seven years, experts predict that Nephros's Revenue will grow at a rate of 67.43%.

2024 Rev Forecast
$0.02B
2025 Rev Forecast
$0.02B
2026 Rev Forecast
$0.02B
2027 Rev Forecast
$0.01B
2028 Rev Forecast
$0.02B
2029 Rev Forecast
$0.02B
2030 Rev Forecast
$0.02B

Nephros Dividend per Share Forecast for 2023 - 2025 - 2030

Nephros Free Cash Flow Forecast for 2023 - 2025 - 2030

Nephros EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Nephros's EBITDA has decreased by 7.44%, from $-4.30M to $-3.98M. In the next year, analysts predict that EBITDA will jump to $-4.12M – up 3.47% from the current level. Looking ahead to eight years, experts forecast that EBITDA will grow by 3.52%.

2023 EBITDA Forecast
$-4118106.00
2024 EBITDA Forecast
$-4180563.94
2025 EBITDA Forecast
$-4148094.89
2026 EBITDA Forecast
$-4091957.34
2027 EBITDA Forecast
$-4100959.65
2028 EBITDA Forecast
$-4127342.49
2029 EBITDA Forecast
$-4134358.97
2030 EBITDA Forecast
$-4120164.34

Nephros EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Nephros's EBIT has fallen from $-4.50M to $-4.34M – a 3.56% decrease. According to 1 prominent analysts, Nephros's EBIT will fall by 88.94% in the next year, reaching $-480.00k. Over the next seven years, experts predict that Nephros's EBIT will grow at a rate of 1648.83%.

2024 EBIT Forecast
$-480000.00
2025 EBIT Forecast
$690.00k
2026 EBIT Forecast
$0.00B
2027 EBIT Forecast
$0.01B
2028 EBIT Forecast
$-59203.30
2029 EBIT Forecast
$-2122679.15
2030 EBIT Forecast
$-75899294.10

Nephros EPS Price Prediction Forecast for 2023 - 2025 - 2030

Nephros's EPS has grown In the last four years, rising from $-0.52 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $-0.04 – an increase of 100.00%. For the next seven years, experts predict that Nephros's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$-0.04
2025 EPS Forecast
$0.04
2026 EPS Forecast
$0.01
2027 EPS Forecast
$0.01
2028 EPS Forecast
$0.01
2029 EPS Forecast
$0.02
2030 EPS Forecast
$0.02